Hints and tips:
Related Special Reports
...Sir Peter Donnelly, chief executive of Genomics, said the company’s tests, which are based on a cheaper and easier form of genetic sequencing called genotyping, help discover individuals at high risk who...
...Counterparts to her US Ark Innovation and Ark Genomic Revolution ETFs, as well as a third strategy “tailored specifically for the European market” focusing on artificial intelligence and robotics, are expected...
...Christoph Schweizer told the Financial Times that AI and generative AI were “a huge boost” to revenues in the past year as companies move from experimenting with the technology to “at-scale deployment”....
...While some richer nations dither over how to deal with these advances, scientists in lower and middle income countries are seizing the opportunity to give agriculture a targeted genomic reboot....
...A dispute over developing a genomic repository threatens to unravel a pandemic accord, underlining the struggle to build a universal surveillance system after the coronavirus outbreak exposed sharp inequalities...
...Spit into a tube, post it to a lab and a genetics testing company will email you the results for as little as $99....
...Pharmaceuticals companies are using AI to identify new molecules as targets for possible anticancer drugs....
...said her California-based Innovative Genomics Institute was focusing on this....
...A dearth of career scientists and public funding risks undermining efforts to use technological breakthroughs to tackle the biggest health threats, the head of a leading international research organisation...
...US lawmakers are seeking to restrict companies with federal funding from contracting with biotech groups deemed to be a threat to national security....
...The company’s net profit increased 21.3 per cent to Rmb10.7bn, flattered by a favourable exchange rate....
...Charpentier formed Crispr Therapeutics, a Nasdaq-listed company, in 2013 to boost the development of gene editing to treat diseases....
...Genomics England has a follow-up programme, Cancer 2.0, which aims to extend the diagnostic potential of whole genome sequencing....
...The company’s work to date has involved analysing thousands of donated human livers to develop an understanding of the causes of disease, and studying whether making changes to RNA — a vital molecule for...
...Ancient migration patterns reveal why some Europeans are more at risk than others from a range of diseases including multiple sclerosis and Alzheimer’s, according to groundbreaking genomic research....
...London market is a scapegoat for poor performance When a UK company’s share price goes south, simply blame the London market....
...Both sides can then benefit if investors put a premium on companies incorporated there....
...The Cambridge group’s work has started to “open up a door into almost unlimited reprogramming in biology”, said Ben Davis, a professor of chemical biology at Oxford university....
...One of the key points of contention centres around Article 12, which would create a genomic repository....
...Professor Matt Brown, chief scientific officer at Genomics England, a government-owned company, told the Financial Times the price of sequencing a whole genome was “plummeting”, having fallen from $1,000...
...He recently won board seats at utility AEP and airline JetBlue, and continues to pressure genomics specialist Illumina after ousting some of its directors last year....
...He has won board seats at utility AEP and airline JetBlue after building large stakes in the companies, and continues to pressure genomics specialist Illumina after ousting some of its directors last year...
...The latest £200mn project was a collaboration funded by the government, Wellcome Trust, Britain’s biggest biomedical charity, and four pharmaceutical companies....
...The company this week reported burning almost $4bn in cash in the first quarter as production rates slowed....
...The filing requires developers to set up a local company or use a local publisher and host the back end of the app in China, said Bishop, who predicted that most companies would end up operating a second...
International Edition